This is a dummy test for home page
BOSTON (Reuters) – A federal judge on Monday rejected a lawsuit by Massachusetts’ attorney general challenging new rules by President Donald Trump’s administration that make it easier for employers to avoid providing insurance that covers women’s birth control.
Source: Reuters Medical News
BOSTON (Reuters) – Impax Laboratories Inc went to trial on Monday over allegations by major retailers and consumers that the company agreed to delay launching a generic version of acne medication Solodyn in exchange for millions of dollars from the manufacturer.
Source: Reuters Medical News
(Reuters Health) – Nearly all the adolescents in an economically disadvantaged, largely minority population in San Francisco who were tested for a tobacco-smoke byproduct showed evidence of regular exposure, a small study found.
Source: Reuters Medical News
BRUSSELS (Reuters) – Europe’s drinks sector announced plans on Monday to inform consumers more about the energy content and ingredients in beer, wine and spirits in a self-policing move, but critics said much of this information would only be available online.
Source: Reuters Medical News
(Reuters Health) – Participation in high school football has been steadily falling in recent years amid mounting concerns about the potential for traumatic brain injuries to lead to lasting health problems, a U.S. study suggests.
Source: Reuters Medical News
PARIS (Reuters) – Mexico reported two outbreaks of highly pathogenic H7N3 bird flu virus in the central part of the country, of which one at chicken farm, the World Organisation for Animal Health said on Monday, citing a Mexican agriculture ministry report.
Source: Reuters Medical News
BOSTON (Reuters) – Impax Laboratories Inc went to trial on Monday over claims by major retailers and consumers that the company agreed to delay launching a generic version of Solodyn in exchange for millions of dollars from the acne medication’s manufacturer.
Source: Reuters Medical News
(Reuters) – Anthera Pharmaceuticals Inc said on Monday it would evaluate all strategic options after its lead drug failed in a late-stage trial, sending its shares down 80 percent in premarket trading.
Source: Reuters Medical News
(Reuters) – Biogen Inc said on Monday it would buy Pfizer Inc’s experimental treatment for a symptom associated with schizophrenia in a deal that could near $600 million and mark its foray into the emerging market for neuropsychiatry.
Source: Reuters Medical News
(Reuters) – GlaxoSmithKline has won a further reprieve for its blockbuster Advair lung drug after U.S. regulators insisted Hikma Pharmaceuticals conduct a further clinical study evaluating its generic version of the drug.
Source: Reuters Medical News